Antiemetic drug fosaprepitant exerts anti-tumor effects against NSCLC by targeting FAK to inhibit AKT and JNK/c-Jun pathways
Ying Wang(Chinese Academy of Sciences), Zhaowei Yan(Soochow University), Jianjie Zhu(Soochow University), Yuanyuan Zeng(Sichuan University), Jianjun Li(National Research Council Canada), Yihua Zhang(China Pharmaceutical University), Di Lu(Fudan University), Chenying Shu(Soochow University), Chenkang Ma(Soochow University), Yuna Shao(Soochow University), Huiling Zhang(Shandong Agricultural University)
Cited by 1
Related Papers
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
|International Journal of Oncology|2016|385
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
|Molecular Cancer|2018|369
PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
|International Journal of Clinical Oncology|2017|315
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
|International Journal of Oncology|2014|314
Halide-Rich Synthesized Cesium Lead Bromide Perovskite Nanocrystals for Light-Emitting Diodes with Improved Performance
|Chemistry of Materials|2017|302